0001808805-22-000075.txt : 20220628 0001808805-22-000075.hdr.sgml : 20220628 20220628181738 ACCESSION NUMBER: 0001808805-22-000075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220627 FILED AS OF DATE: 20220628 DATE AS OF CHANGE: 20220628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mowry Anna CENTRAL INDEX KEY: 0001856938 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39434 FILM NUMBER: 221051321 MAIL ADDRESS: STREET 1: C/O NAUTILUS BIOTECHNOLOGY, INC. STREET 2: 201 INDUSTRIAL RD. #310 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc. CENTRAL INDEX KEY: 0001808805 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2701 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-333-2001 MAIL ADDRESS: STREET 1: 2701 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III DATE OF NAME CHANGE: 20200408 4 1 wf-form4_165645463634483.xml FORM 4 X0306 4 2022-06-27 0 0001808805 Nautilus Biotechnology, Inc. NAUT 0001856938 Mowry Anna C/O NAUTILUS BIOTECHNOLOGY, INC. 2701 EASTLAKE AVENUE EAST SEATTLE WA 98102 0 1 0 0 CFO and Treasurer Common Stock 2022-06-27 4 P 0 5500 2.7499 A 39250 D Includes 1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan. /s/ Matthew B. Murphy, as Attorney-in-Fact 2022-06-28